KCNK1 and type 2 diabetes mellitus: In our previous study using a genetic model of type 2 diabetes (the db/db mouse), we assessed potential effects on genes linked to cardiotoxicity genes (Kcnk1, Asah2, B4glant, MMP-3), and reported no adverse effects after ENOblock treatment7,73.